Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,132 Diabetes
clinical trials

Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Washington, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Bellflower, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling, Phase III
Updated: 12/31/1969
Biotech Pharmaceutical Group
mi
from
Miami, FL
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Endocrinology Clinical Trial
Type 1 Diabetes Extension Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Iowa Health Care Division of Pediatric Endocrinology
mi
from
Iowa City, IA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Homestead, FL
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lampasas, TX
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus Patients
Status: Enrolling, Phase III
Updated: 1/25/2016
Mylan Investigator Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
Status: Enrolling, Phase IV
Updated: 6/22/2016
Comprehensive Weight Control Center
mi
from
New York, NY
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Multi-clinic Action Trial to Control Hyperglycemia and Hypertension
Status: Enrolling
Updated: 5/5/2016
Cicero Health Center of Cook County
mi
from
Cicero, IL
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Eastmoreland Internal Medicine
mi
from
Memphis, TN
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional Medical Clinic
mi
from
Rapid City, SD
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
SSM Cardinal Glennon Children's Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lufkin, TX
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Alliance
mi
from
Alhambra, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Chattanooga Research and Medicine (CHARM)
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
WR-ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
AA MRC LLC Ahmed Arif Medical Research Center
mi
from
Flint, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Diabetes and Thyroid Center of Fort Worth, PLLC
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Grace Research, LLC
mi
from
Huntsville, TX
Click here to add this to my saved trials
Type 1 Diabetes Clinical Trial
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home
Status: Enrolling
Updated: 12/31/1969
IDERC
mi
from
Des Moines, IA
Click here to add this to my saved trials
Type 1 Diabetes Clinical Trial
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home
Status: Enrolling
Updated: 12/31/1969
Initernational Diabetes Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Institute of the Carolinas, PLC
mi
from
Mooresville, NC
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)
Status: Enrolling
Updated: 12/31/1969
La Rabida Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Type1 Diabetes Mellitus Clinical Trial
Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 12/31/1969
Dallas Diabetes Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
National Clinical LLC
mi
from
Hamtramck, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC
mi
from
Houma, LA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
United Health Services Hospitals
mi
from
Johnson City, NY
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Research Institute
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Infinite Clinical Trials
mi
from
Riverdale, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
Status: Enrolling
Updated: 10/11/2017
Southwest Austin Foot & Ankle Clinic, PLLC
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
Status: Enrolling
Updated: 10/11/2017
Foot & Ankle Center of Nebraska
mi
from
Omaha, NE
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Evaluation of TTP399 in Patients With Type 1 Diabetes
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App
Status: Enrolling
Updated: 7/25/2017
Healthcare Innovation and Technology Lab
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
The Impact of Diabetes on REvascularization
Status: Enrolling, Phase
Updated: 12/31/1969
Gunderson Health System
mi
from
La Crosse, WI
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical Research
mi
from
Anaheim, CA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
Buckeye Health and Research, LLC
mi
from
Columbus, OH
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
Sante Clinical Research
mi
from
Kerrville, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Doral, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norcross, GA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Robert E. Torti, MD, PA dba Retina Specialists
mi
from
DeSoto, TX
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Loma Linda University Health Care, Department of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Retina Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Other Clinical Trial
Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics
Status: Enrolling
Updated: 1/16/2018
Barnes-Jewish & Washington University Diabetes Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Diabetes & Endocrinology - Central Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Sestron Clinical Research
mi
from
Marietta, GA
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
California Medical Research Association
mi
from
Northridge, CA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Stonesifer Clinical Research
mi
from
Federal Way, WA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Investigations Specialists-Wisconsin
mi
from
Kenosha, WI
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Northern California Research Corp
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bennington, VT
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cooper City, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Laurelton, NY
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Manassas, VA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mentor, OH
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational Site Number 8402033
mi
from
Opa-locka, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rosedale, NY
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
South Burlington, VT
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Temecula, CA
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Status: Enrolling
Updated: 12/7/2017
Queensland University of Technology
mi
from
Brisbane,
Click here to add this to my saved trials
Type1 Diabetes Mellitus Clinical Trial
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Status: Enrolling, Phase
Updated: 12/31/1969
Diabetes and Metabolism Institute
mi
from
Hope, CA
Click here to add this to my saved trials
1 … 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 … 41